Clinical Trial Update: Rituximab Treatment in Sjogren's Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Rituximab for Sjogren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Sjogren's Syndrome | Phase 1, Phase 2 | Status: COMPLETED